Finland· FI-REL-REL13210
TRIZIVIR
A zidovudine, lamivudine and abacavir product containing abacavir sulfate + lamivudine + zidovudine, registered in Finland by ViiV Healthcare BV. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Zidovudine, lamivudine and abacavir is registered in 10 of 19 countries.
Countries holding a registration under ATC J05AR04 (zidovudine, lamivudine and abacavir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Zidovudine, lamivudine and abacavir · ATC J05AR04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Abacavir sulfate + Lamivudine + Zidovudine
- Manufacturer
- ViiV Healthcare BV
- Country
- Finland (FI)
- ATC code
- J05AR04
- ATC class
- Zidovudine, lamivudine and abacavir
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for zidovudine, lamivudine and abacavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zidovudine, lamivudine and abacavir · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Zidovudine, lamivudine and abacavir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRIZIVIRViiV Healthcare BV, Amersfoort
- FranceABACAVIR/LAMIVUDINE/ZIDOVUDINE VIATRIS 300 mg/150 mg/300 mg, comprimé pelliculéVIATRIS SANTE
- NetherlandsAbacavir/Lamivudine/Zidovudine Mylan 300 mg/150 mg/300 mg filmomhulde tablettenMylan Pharmaceuticals Limited
- SpainTRIZIVIR 300 MG/150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- IrelandTrizivir 300 mg/150 mg/300 mg film-coated tabletsViiV Healthcare BV
- United StatesABACAVIR, LAMIVUDINE AND ZIDOVUDINELupin Pharmaceuticals, Inc.
- United KingdomTrizivir 300mg/150mg/300mg tabletsViiV Healthcare UK Ltd
- IcelandTrizivirViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- France · Abacavir/Lamivudine/Zidovudine Viatris
- Iceland · Trizivir
- Italy · Abacavir/Lamivudina/Zidovudina Mylan
- Liechtenstein · Trizivir
- Netherlands · Abacavir/Lamivudine/Zidovudine Mylan
- Norway · Trizivir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eec6baee-d0f0-4904-acb7-f18aa817cda8 GET /v1/drugs/eec6baee-d0f0-4904-acb7-f18aa817cda8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "300 mg / 150 mg / 300 mg",
"atc_label": "tsidovudiini, lamivudiini ja abakaviiri",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/00/156/002-004",
"fimea_rel_id": "REL13210",
"authorised_at": "2001-01-09"
}See everything about zidovudine, lamivudine and abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.